Pemetrexed - Articles - Scientific Research Publishing

Safety and efficacy of pemetrexed in gynecologic cancers: A systematic literature review (Review)

David Scott Miller, Datchen Fritz Tai, Coleman Obasaju, Ignace Vergote

Modern Chemotherapy Vol.2 No.2，April 15, 2013

DOI: 10.4236/mc.2013.22004 5,551 Downloads 10,913 Views Citations
Good Response to Pemetrexed after Treatment Failure with Another Thymidylate Synthase Inhibitor in Lung Adenocarcinoma: A Case Report (Articles)

Fumihiko Hirai, Eiko Inamasu, Gouji Toyokawa, Tsukihisa Yoshida, Kaname Nosaki, Tomoyoshi Takenaka, Masafumi Yamaguchi, Mitsuhiro Takenoyama, Takashi Seto, Yukito Ichinose

Journal of Cancer Therapy Vol.5 No.8，July 10, 2014

DOI: 10.4236/jct.2014.58085 2,465 Downloads 3,565 Views Citations
Prospective Analysis of Patients Treated with Chemotherapy in Metastatic Adenocarcinoma of Lung—Single Centre Experience (Articles)

B. J. Srinivasa, L. P. Bhanu, Girish Badarke, Mohammad Nasiruddin, Sulav Sapkota, D. Tousif, Vishal Kulkarni, P. K. Kiran, Vinu Sarathy, G. S. Deepika, Amritanshu Ram, Raghavendra Rao, Shekar Patil, Radheshyam Naik

Journal of Cancer Therapy Vol.8 No.9，September 20, 2017

DOI: 10.4236/jct.2017.89073 1,062 Downloads 2,090 Views Citations
The Clinical Investigation of Pemetrexed Plus Carboplatin as an Active and Tolerable Treatment Plan in Chinese Elderly Patients with Advanced Lung Adenocarcinoma (Articles)

Yu-Quan Wu, Jun Yang, Xi-Jian Zhou, Peng Li, Xiao-Qiang Fan, Guang-Zhou Lu, Yan-Juan Pan, Xiang-Yong Li, Fu-Lin Yan

Journal of Cancer Therapy Vol.2 No.3，August 8, 2011

DOI: 10.4236/jct.2011.23042 6,040 Downloads 10,282 Views Citations
The Role of Thymidylate Synthase in Pemetrexed-Resistant Malignant Pleural Mesothelioma Cells (Articles)

Tohru Obata, Motohiro Tanaka, Yuka Suzuki, Takuma Sasaki

Journal of Cancer Therapy Vol.4 No.6，July 17, 2013

DOI: 10.4236/jct.2013.46119 3,240 Downloads 5,164 Views Citations
Unexpected Dramatic Response of Pretreated Invasive Thymic Malignancies on Pemetrexed-Case Report and Review of Current Treatment Modalities (Articles)

Priscilla Raman, Veerle Surmont

Open Journal of Respiratory Diseases Vol.2 No.4，November 27, 2012

DOI: 10.4236/ojrd.2012.24016 5,204 Downloads 8,486 Views Citations
Pemetrexed and Gemcitabine for Chemotherapy Refractory Colorectal Cancer—Results of a Phase II and Translational Research Study (Articles)

Karen-Lise Garm Spindler, Niels Pallisgaard, Rikke Fredslund Andersen, John Ploen, Anders Jakobsen

Journal of Cancer Therapy Vol.4 No.6B，July 5, 2013

DOI: 10.4236/jct.2013.46A2006 3,810 Downloads 5,842 Views Citations
This article belongs to the Special Issue on Colorectal Cancer
Phase II Study of Carboplatin and Pemetrexed Followed by Gefitinib for Patients with Advanced Non-Small Cell Lung Cancer Harboring Sensitive EGFR Mutation (Articles)

Saki Manabe, Fumihiro Oshita, Shuji Murakami, Tetsuro Kondo, Haruhiro Saito, Takeshi Kaneko, Kouzo Yamada

Journal of Cancer Therapy Vol.6 No.15，December 14, 2015

DOI: 10.4236/jct.2015.615132 3,705 Downloads 5,094 Views Citations
Final Results of a Phase II Study of Bevacizumab, Cisplatin and Pemetrexed as First-Line Therapy for Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer (Articles)

Guillermo López Vivanco, Eider Azkona, Sergio Carrera, Aintzane Sancho, Itziar Rubio, Juan Manuel Mañé, Begoña Calvo, Unai Aresti, Aitziber Buque, Inés Marrodán, Alberto Muñoz

Journal of Cancer Therapy Vol.7 No.7，June 27, 2016

DOI: 10.4236/jct.2016.77047 2,461 Downloads 4,992 Views Citations
This article belongs to the Special Issue on Lung Cancer
Predictive Factors of Severe Toxicities of Pemetrexed-Containing Chemotherapy in Patients with Non-Squamous Non-Small Cell Lung Cancer (Articles)

Yuki Katsuya, Yuichiro Takeda, Go Naka, Haruhito Sugiyama

Journal of Cancer Therapy Vol.8 No.11，November 28, 2017

DOI: 10.4236/jct.2017.811087 1,179 Downloads 2,689 Views Citations
New Insights into the Discovery of Novel Drugs to Treat Human Pulmonary Adenocarcinoma (Articles)

Yu Wang, Haishan Zhang, Yingxin Chen, Lining Wang

Journal of Cancer Therapy Vol.10 No.2，February 21, 2019

DOI: 10.4236/jct.2019.102014 957 Downloads 1,883 Views Citations

	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

All	Title	Abstract	Keywords
DOI	Author	Journal	Affiliation
ISSN	Subject

	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Browse Subjects

Publish with us

Home

About SCIRP

Service

Policies